AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Covered by 2 sourcesPublished 3 hours ago

AstraZeneca has entered a deal with AI drug discovery firm Insitro, paying $40 million upfront and potentially up to $1.5 billion if milestones are met, to advance AI-driven therapeutics.

Covered by 2 sources

The Wall Street Journal
ET AI (The Economic Times)

#astrazeneca #biopharmaceuticals #drug-discovery #insitro #virtual-human

AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Covered by 2 sources

More in Healthcare

Dyson CameraJet Review: $500 AI Toothbrush Has Reliability, Water Issues

SimBioSys Wins FDA Clearance for Breast Cancer Recurrence AI Tool

Spatiotemporal AI-based modeling of gene regulation and variant effects in the developing human brain using Seal